Page 2 - Best Chordoma doctors: TOP 47 doctors

Associate Professor at the Medical University of Vienna and Deputy Head of its Clinical Division of Oncology – one of Austria's top cancer research centers.

• Over two decades specializing in medical oncology and internal medicine
• Internationally recognized for expertise in solid tumor targeted therapies
• Focuses on personalized cancer medicine and biomarker-driven treatment
• Contributes to translational research and designs new precision treatment strategies
• Senior consultant for individualized systemic cancer therapy at Wiener Privatklinik

Professor Keil specializes in interventional radiology, performing complex medical interventions using advanced imaging techniques at Medical Center in Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound-guided procedures
• Former leading doctor at University Hospital of Aachen
• Chief Physician at Academic Hospital Solingen since 2022

Associate Professor Dr. Yusuf Acikgoz brings international expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in Medical Oncology with a focus on clinical trials
• Participated in Phase III studies like CheckMate-649 and Fortitude-101
• Member of American Society of Clinical Oncology (ASCO)
• Certified in Good Clinical Practice and Human Subjects Protection

49 years of experience of experience specializing in virotherapy – one of the newest fields in immunology – at Pallas Clinic.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Expert in immunological treatments that can be tailored to specific conditions

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Nail Paksoy brings specialized expertise in oncology, with a focus on complex cases at Medipol Bahçelievler Hospital.

• Board-certified in Medical Oncology by ESMO
• Published multiple studies on rare cancers and innovative treatments
• Active participant in international clinical trials for oncology
• Associate Professor at Istanbul Medipol University

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Topcu brings international expertise from MD Anderson and Sunnybrook Odette Cancer Center to Biruni University Hospital.

• Specializes in rare cancers including chordoma and sarcomas
• Member of ESMO and ASCO – global oncology standards
• Trained at top institutions in the US, Canada, and Turkey
• Works across multiple cancer types with complex cases

Specialized in radiation oncology with training from Marmara University, renowned for its rigorous medical program.

• Trained at Marmara University's Department of Radiation Oncology
• Completed undergraduate studies in medicine at Marmara University
• Education includes international experience from Azerbaijan

Prof. Filippini specializes in surgical treatment of locally advanced tumors, with training at Memorial Sloan Kettering Cancer Center and City of Hope Oncology Center.

• Over 46 years of experience of experience in oncological surgery
• Expert in minimally invasive, laparoscopic, and robotic techniques
• Authored over 100 scientific publications and two monographs
• Professor at the University of Chieti since the 1990s

Dr. Sridhar P.S. specializes in radiotherapy with a focus on neuro-oncology, bringing extensive expertise to complex cases like chordoma.

• Over 30 years of experience of experience in radiotherapy
• Member of the Society for Neuro-Oncology
• Trained at Banaras Hindu University and National Board Of Examination
• Part of the Bangalore Oncology Group

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries over 30 years of experience, specializing in Breast and Thoracic Surgical Oncology at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Involved in 200+ clinical trials, including phase 1-3 studies
• Professor for DNB Superspecialty Surgical Oncology and Breast Surgery
• Focuses on improving patients' quality of life post-treatment

Dr. Shruti Kate specializes in treating advanced cancers with innovative approaches like immunotherapy and metronomic therapy. She trained at Tata Memorial Hospital, a leader in oncology care.

• Fellowship in Medical Oncology from Tata Memorial Hospital
• Expert in lung, breast, and gynecological cancers
• Member of ASCO, ESMO, and other top oncology societies
• Presented research at the World Conference on Lung Cancer